Company profile

Ultima Genomics

Ultima Genomics, founded in 2016, has raised $600 million across Seed, Series A, and Series B funding rounds, reaching a $1 billion valuation. Its largest raise was a $430 million Series B in 2021 led by SoftBank Vision Fund and Illumina Ventures. Ultima Genomics develops high throughput DNA sequencing technologies aimed at reducing cost and increasing speed and accuracy. With strong investor backing, the company is positioned to scale genomic research, precision medicine applications, and adoption of affordable next generation sequencing solutions globally.

Back to profiles

Quick facts

Total funding: $600 million
Valuation: $1 billion
Founded: 2016

Notable investors

SoftBank Vision Fund
Illumina Ventures

Reach buyers like Ultima Genomics on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Ultima Genomics
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Ultima Genomics.

The 14-day trial ships every feature, no card required.

Start free →